Scarica l'app Stockscreener
24.87
3.53%
-0.91
Dopo l'orario di chiusura:
24.87
Precedente Chiudi:
$25.78
Aprire:
$26.22
Volume 24 ore:
278.52K
Relative Volume:
0.39
Capitalizzazione di mercato:
$907.70M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-6.99%
1M Prestazione:
-5.04%
6M Prestazione:
+154.82%
1 anno Prestazione:
-14.92%
Intervallo 1D:
$24.24
$27.03
Intervallo di 1 settimana:
$24.24
$27.42
Portata 52W:
$7.13
$42.27
Rapport Therapeutics Inc Stock (RAPP) Company Profile
Nome
Rapport Therapeutics Inc
Settore
Industria
Telefono
857-321-8020
Indirizzo
99 HIGH STREET, BOSTON
Confronta RAPP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RAPP
Rapport Therapeutics Inc
|
24.87 | 1.15B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Rapport Therapeutics Inc Stock (RAPP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-16 | Iniziato | Truist | Buy |
| 2025-08-06 | Iniziato | H.C. Wainwright | Buy |
| 2025-04-08 | Iniziato | Citizens JMP | Mkt Outperform |
| 2024-07-02 | Iniziato | Jefferies | Buy |
| 2024-07-02 | Iniziato | Stifel | Buy |
| 2024-07-02 | Iniziato | TD Cowen | Buy |
Mostra tutto
Rapport Therapeutics Inc Borsa (RAPP) Ultime notizie
How to recover losses in Rapport Therapeutics Inc. stock2025 Trading Volume Trends & Real-Time Market Sentiment Alerts - newser.com
What candlestick patterns are forming on Rapport Therapeutics Inc.July 2025 Analyst Calls & Low Risk High Reward Ideas - newser.com
Rapport Therapeutics Inc. stock chart pattern explainedTrade Analysis Report & Short-Term Trading Opportunity Alerts - newser.com
Has Rapport Therapeutics Inc. found a price floorEarnings Summary Report & Community Supported Trade Ideas - newser.com
Published on: 2025-10-15 06:26:38 - newser.com
Multi factor analysis applied to Rapport Therapeutics Inc.2025 Fundamental Recap & Capital Protection Trading Alerts - newser.com
Smart tools for monitoring Rapport Therapeutics Inc.’s price actionWeekly Market Summary & Reliable Breakout Stock Forecasts - newser.com
Why Rapport Therapeutics Inc. stock could be next big winner2025 Top Gainers & Reliable Price Breakout Signals - newser.com
Can volume confirm reversal in Rapport Therapeutics Inc.Wall Street Watch & Risk Managed Trade Strategies - newser.com
Published on: 2025-10-14 03:02:31 - newser.com
Volatility clustering patterns for Rapport Therapeutics Inc.Stop Loss & Verified Momentum Stock Watchlist - newser.com
Analysts Set Rapport Therapeutics, Inc. (NASDAQ:RAPP) PT at $35.33 - Defense World
Statistical indicators supporting Rapport Therapeutics Inc.’s strengthSell Signal & AI Based Trade Execution Alerts - newser.com
Analyzing net buyer seller activity in Rapport Therapeutics Inc.Trade Analysis Summary & Safe Entry Trade Reports - newser.com
Is Rapport Therapeutics Inc. trending in predictive chart models2025 Momentum Check & Weekly Sector Rotation Insights - newser.com
Published on: 2025-10-12 22:23:14 - newser.com
Identifying reversal signals in Rapport Therapeutics Inc.Weekly Trading Summary & Risk Controlled Stock Pick Alerts - newser.com
Rapport Therapeutics, Inc. (NASDAQ:RAPP) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Key metrics from Rapport Therapeutics Inc.’s quarterly dataJuly 2025 Levels & Risk Controlled Daily Plans - newser.com
Weiss Ratings Reaffirms Sell (D-) Rating for Rapport Therapeutics (NASDAQ:RAPP) - MarketBeat
Applying big data sentiment scoring on Rapport Therapeutics Inc.Quarterly Profit Summary & Weekly Watchlist of Top Performers - newser.com
Rapport Therapeutics, Inc. (RAPP) Stock Analysis: Unveiling Its 93.40% Potential Upside in the Booming Biotech Sector - DirectorsTalk Interviews
Should you hold or exit Rapport Therapeutics Inc. nowMarket Trend Review & Real-Time Volume Analysis Alerts - newser.com
Rapport Therapeutics (NASDAQ:RAPP) Stock Price Up 2.3%What's Next? - MarketBeat
What analysts say about Rapport Therapeutics Inc stockStock Buy Signals & Invest Now – Opportunity Window Closing - earlytimes.in
Full technical analysis of Rapport Therapeutics Inc. stockJuly 2025 Levels & Verified Chart Pattern Trade Signals - newser.com
Applying Elliott Wave Theory to Rapport Therapeutics Inc.Weekly Volume Report & Weekly Chart Analysis and Guides - newser.com
Momentum divergence signals in Rapport Therapeutics Inc. chartJuly 2025 Gainers & Weekly High Conviction Trade Ideas - newser.com
How institutional ownership impacts Rapport Therapeutics Inc. stockWeekly Trend Recap & Capital Efficient Trade Techniques - newser.com
Using data filters to optimize entry into Rapport Therapeutics Inc.July 2025 Closing Moves & Target Return Focused Stock Picks - newser.com
Rapport Therapeutics, Inc. (RAPP) Stock Analysis: Exploring an 81% Upside Potential in CNS Therapeutics - DirectorsTalk Interviews
Rapport Therapeutics (RAPP) Is Up 14.3% After Positive RAP-219 Phase 2a Results in Epilepsy - Sahm
Is Rapport Therapeutics Inc. stock recession proofMarket Risk Report & Verified Short-Term Plans - newser.com
Rapport Therapeutics (NASDAQ:RAPP) Shares Down 7.3%Here's What Happened - MarketBeat
Why Rapport Therapeutics (RAPP) Is Up 6.3% After Positive Phase 2a Epilepsy Drug Results and Analyst Optimism - Yahoo Finance
Rapport Therapeutics (NASDAQ:RAPP) Shares Gap DownTime to Sell? - MarketBeat
Rapport Therapeutics Inc Azioni (RAPP) Dati Finanziari
Non sono disponibili dati finanziari per Rapport Therapeutics Inc (RAPP). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Rapport Therapeutics Inc Azioni (RAPP) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Ceesay Abraham | Chief Executive Officer |
Sep 17 '25 |
Sale |
26.32 |
40,835 |
1,074,725 |
585,412 |
| Ceesay Abraham | Chief Executive Officer |
Sep 17 '25 |
Sale |
26.32 |
35,585 |
936,472 |
46,144 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):